We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summary of quality assurance (QA) visit to City, Sandwell & Walsall held on 18 March 2019.
Summary of existing evidence on community champion approaches and discussion of implications, including for pandemic response and recovery.
Report showing opportunities and challenges for community pharmacy teams to further support the public’s health.
Briefing for local authorities on the increasing role of community pharmacy in public health, working with councils and other community partners.
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
Leaflet for people eligible for COVID-19 vaccination who have had their first dose of AstraZeneca vaccine and have concerns about having the second dose.
This information explains what a suspected screening result for cystic fibrosis (CF) means.
Executive summary of the quality assurance (QA) visit to Derbyshire Community Health Services NHS Foundation Trust cervical screening programme on 12 September 2019.
This document explains the roles and responsibilities of NHS diabetic eye screening (DES) programme clinical leads.
How to submit research proposals to the NHS Diabetic Eye Screening (DES) Programme.
This protocol sets out nationally agreed methods for monitoring patient doses from routine x-ray examinations.
Information about 1,2-dibromoethane for use in responding to chemical incidents.
Executive summary of quality assurance (QA) visit to Durham and Darlington held on 26 September 2019.
EPPs and non-EPPs carried out in ear, nose and throat (ENT) and oral and maxillofacial surgery (OMFS), categorised by levels of risk of bleed-back.
Guidance on fiscal and pricing policies that aim to improve health outcomes.
Poster highlighting the importance of adults with long term health conditions having the flu vaccination
Practice notes on managing critically ill children with H1N1 influenza infections.
This report summarises the topics discussed and work done by the HAIRS group in 2017.
Executive summary of quality assurance (QA) visit to Hampshire bowel cancer screening programme held on 13 December 2017.
Executive summary of quality assurance (QA) visit to Hampshire Hospitals NHS Foundation Trust's antenatal and newborn screening programme on 4 October 2016.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).